colab
we are not here to fit in
.png)
designed for
systems change
the cancer collaborative is a catalyst for change, where disruptive ideas and creative strategy come together to challenge systems, influence policy, and drive real impact for people affected by cancer.
#KNOWVEMBER
IS PRECISION ONCOLOGY AWARENESS MONTH
this month is about understanding the science that’s already changing the future of cancer care and the work we do all year to make it accessible to everyone.
FOR INDUSTRY
help close the gap between innovation and access
advances in biomarker testing need a path to the people who could benefit. industry has a role in helping build that path across canada, through collaboration on evidence, funding, implementation and the challenges that stand in the way of equitable access.
explore where your expertise and support can contribute to progress, alongside people living with cancer, advocates, clinicians, laboratories, health system leaders and decision makers
SHARED PRIORITIES
where we can make progress together
connect expertise and resources to the challenges shaping testing access across canada
align testing & treatment access
help address the gaps between a treatment becoming available and the testing needed to identify who may benefit.
support implementation
work with laboratories, clinical teams and health system partners on what it takes to put testing into practice, not just introduce it.
reach beyond major centres
help identify and address the barriers facing community hospitals and people receiving care outside large cancer centres.
strengthen understanding
support independent, patient facing information and opportunities for patients, caregivers & professionals to exchange perspectives.
build sustainable pathways
support independent, patient-facing information and opportunities for patients, caregivers and professionals to exchange perspectives.
what you can do
ADVOCACY
there are opportunities to improve testing access within your organisation’s work and through collaboration across the system. our guide sets out practical actions for industry and diagnostics partners—from strengthening evidence for testing to supporting sustainable funding and implementation.
help connect innovation, implementation and equitable access.
.png)
your work is part of the story. tell us the part we don’t see.
what do you wish patients, colleagues or decision makers understood about your part in biomarker testing? share a moment that stayed with you, something you’ve helped change, or the work that rarely gets noticed.
add your perspective to the #KNOWvember storybank—in a few words, a short video or a conversation with us. start with what you want people to know
independent evidence on where testing access stands in canada
possible avenues to speed up patient access
Current and Future Challenges of Innovative Oncology Drugs Development
read/downlaod
CBQA 2024. Precision Oncology in Cnada. Who Pays?
After this episode, the participant will be able to:
1. Summarize the current regulatory and funding processes for precision oncology
diagnostics in Canada.
2. Identify key differences between the funding pathways for oncology drugs and
diagnostic tests, emphasizing the challenges and gaps in the existing system.
3. Analyze the barriers to accessing precision oncology diagnostics, including the
lack of standardized criteria across provinces and the variability in HTA
processes.
read/downlaod
beat cancer policy paper
the BEAT cancer coalition's policy paper. the coalition brings together patient advocates, clinicians, academic centres and industry around one goal: timely, appropriate advanced molecular testing for every cancer patient in canada, wherever they live.
read/downlaod
need more specialized
information ?
for advocates &
patient groups
Policy briefs, shared recommendations and campaign resources to support your work. Bring lived experience into the conversation and connect with opportunities for collective action
for providers
Testing and implementation resources, policy insights and patient information. Explore where clinical expertise can help address gaps and shape change
for industry
Policy and advocacy resources, collaboration opportunities and ways to support accessible testing
for health system
decision makers
Provincial comparisons, policy evidence and perspectives from people delivering and receiving care. Inform decisions with a fuller picture of implementation and its impact
help close the gap between innovation and access.
Partner with us to support clear information about precision oncology, bring patient and professional perspectives into the conversation, and help make the challenges around biomarker testing more visible.
We welcome conversations with industry partners about education, knowledge sharing and initiatives that respond to the needs of people living with cancer, caregivers and care teams, during #KNOWvember and year round.
colab | #KNOWvember
independent, non promotional information on precision oncology and biomarker testing in canada, from the cancer collaborative | le collaboratoire cancer. reviewed and refreshed every year.
explore
for industry